Dr Jennifer Martin Discusses How Insomnia Has Evolved & Affects In Insurance Coverage
In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, shares her thoughts on how non-pharmacologic treatments for the management of insomnia has evolved over the past few years and how the increased use of behavioral treatments might affect insurance coverage.
This video was taken on June 3, 2013, at the Sleep 2013 Conference in Baltimore, MD.
Progress in treating multiple myeloma, or cancer of the plasma cells in bone marrow, has advanced significantly over the past decade. Today, questions about the disease often involve finding a treatment that balances the goal of putting a patient into remission – especially if stem cell transplantation is a possibility – against the toxicity of the treatment itself.
With grants from government sources looking less certain, partnerships between academic research center and pharmaceutical companies are more important than ever to keep breakthrough hematology therapies in the pipeline, said Burt Adelman, MD, a hematologist who serves as executive vice president and chief medical officer for Dyax Inc.
New therapies to treat chronic lymphocytic leukemia (CLL) will receive plenty of attention this week at the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans. At an education session that opened the meeting Saturday, a physician with the Mayo Clinic made it clear that cost considerations are a reality for many older patients.
The Affordable Care Act has dramatically increased the cost of buying a health insurance plan on the individual market in California, Texas, Florida, New York, Illinois, Georgia, and North Carolina, states that account for more than half of America’s uninsured adults.
Ora Pescovitz, MD, CEO of the Michigan Health System, says that academic medical centers like those at the University of Michigan are among those in the lead with patient-centered medical homes (PCMHs) and accountable care organizations (ACOs).
The individual mandate of the Affordable Care Act was intended to incentivize uninsured Americans into purchasing health insurance on the exchanges. However, latest findings show that the penalty may not be enough.
By all accounts, the shopping experience on HealthCare.gov has improved significantly. That means customers can routinely access information about what health plans and subsidies are available and select the product of their choice.
